Publications

Sort by: Date | Author | Title

Snipsøyr, M. G., Wiggers, H., Knudsen, J. B., Ludvigsen, M., Poulsen, S. H., Petersen, E. & Honoré, B. (2013). Identification of putative, novel biomarkers for infective endocarditis by proteomic analysis. Poster session presented at 30th annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases, Aarhus, Denmark.
Kilpivaara, O., Ristolainen, H., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., D'Amore, F. A. & Lauri, A. A. (2014). Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma with exome sequencing. Blood, 121(24).
Ristolainen, H., Kilpivaara, O., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., D'Amore, F. A. & Aaltonen, L. (2015). Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma by exome sequencing. British Journal of Haematology, 170(3), 428-31.
Ristolainen, H., Kilpivaara, O., Kamper, P., Taskinen, M., Saarinen, S., Leppä, S., d'Amore, F. & Aaltonen, L. A. (2015). Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing. British Journal of Haematology, 170(3), 428-431. https://doi.org/10.1111/bjh.13295
Shelton, V., Detroja, R., Liu, T., Isaev, K., Silva, A., Passerini, V., Bakhtiari, M., Calvente, L., Hong, M., He, M. Y., Modi, S., Hershenfeld, S. A., Ludvigsen, M., Madsen, C., Hamilton-Dutoit, S., d’Amore, F. A., Brodtkorb, M., Johnson, N. A., Baetz, T. ... Kridel, R. (2024). Identification of genetic subtypes in follicular lymphoma. Blood Cancer Journal, 14(1), Article 128. https://doi.org/10.1038/s41408-024-01111-w
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2012). High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01). Blood, 118, 331.
d'Amore, F. A., Jantunen, E. & Relander, T. (2009). Hemopoietic Stem Cell Transplantation in T-cell Malignancies:Who, When and How? Current Hematologic Malignancy Reports, 4, 236-244.
D'Amore, F. A., Relander, T., Lauritzen, G. F., Jantunen, E., Mannisto, S., Meyer, P., Ellin, F., Pedersen, M. B. & Toldbod, H. (2016). Hematopoietic stem-cell transplantation in peripheral T-cell lymphomas. In Hematopoietic cell transplants - Concepts, controversies and future directions (Vol. 37, pp. 343-347). Cambridge University Press. https://doi.org/10.3760/cma.j.issn.0253-2727.2016.04.020
Massa, G., Bogliolo, G., d'Amore, F. A., Muzzulini, C., Ghio, R. & Pannacciulli, I. (1982). Haemopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin. Journal of the National Cancer Institute, 68, 971-976.
de Leval, L., Alizadeh, A. A., Bergsagel, P. L., Campo, E., Davies, A., Dogan, A., Fitzgibbon, J., Horwitz, S. M., Melnick, A. M., Morice, W. G., Morin, R. D., Nadel, B., Pileri, S. A., Rosenquist, R., Rossi, D., Salaverria, I., Steidl, C., Treon, S. P., Zelenetz, A. D. ... Scott, D. W. (2022). Genomic profiling for clinical decision making in lymphoid neoplasms. Blood, 140(21), 2193-2227. https://doi.org/10.1182/blood.2022015854
Heavican, T. B., Bouska, A., Yu, J., Lone, W. G., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., Greiner, T. C., Vose, J., Weisenburger, D. D., Lachel, C., Wang, C., Fu, K., Stevens, J., Lim, S. T., Ong, C. K. ... Iqbal, J. (2019). Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood, 133(15), 1664-1676. https://doi.org/10.1182/blood-2018-09-872549
Petruskevicius, I., Ludvigsen, M., Kamper, P. M. H., Hjortebjerg, R., Sørensen, B. S., Nielsen, B., Honoré, B. & D'Amore, F. A. (2014). Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.
Kucuk, C., Jiang, B., Hu, X., Gaulard, P., Zhang, W., Xiao, W., Staudt, LM., Iqbal, J., Cornish, A., Kavak, P., Alkan, C., Gong, Q., Yang, Q., Sun, H., D'Amore, F. A., Leppa, S., Liu, W., McKeithan, T. & Chan, WC. (2013). Frequent activating mutations of JAK-Stat Pathway genes in natural killer cell lymphomas. Blood.
D'Amore, F. A., Gomes da Silva, M., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, GF., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, UM., Brown, P. D. N., Boye Hansen, P., Mariz, JM., Jankovska, M., Walewski, J., Doorduijn, J., van Hoof, A., Christiansen, I. ... Toldbod, H. (2011). First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. Blood, 118, 4110.
D'Amore, F. A., Leppä, S., Gomes da Silva, M., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, GF., Pezzutto, A., Van Hoof, A., Van Gelder, M., Doorduijn, J., Wu, KL., Kluin-Nelemans, JC., Lugtenburg, PJ., Jankovska, M., Merup, M., Fagerli, U.-M., Walewski, J., Hagberg, H. ... Toldbod, H. (2012). First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood, 120(57).
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M. & D'Amore, F. A. (2010). favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01). Blood, 116(21).
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G., D'Amore, F. A. & Kolstad, H. (2014). Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine, 71(Suppl 1).